Delve Bio

Delve Bio is a molecular diagnostics company that provides metagenomic next-generation sequencing (mNGS) testing for infectious diseases. Its Delve Detect test analyzes cerebrospinal fluid or plasma for bacteria, viruses, fungi, and parasites, supporting evaluation of conditions such as meningitis and encephalitis. Delve Bio is the exclusive provider of the UCSF mNGS test and offers testing through a CAP-accredited, CLIA-certified laboratory.